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Background: Inflammation contributes to reperfusion injury after acute myocardial infarction (AMI). RNS60 is an isotonic saline solution 
containing charged-stabilized nanostructures introduced by Taylor-Couette Poiseuille flow in the presence of oxygen. RNS60 has shown anti-
inflammatory and cytoprotective effects in models of neuroinflammation and pulmonary inflammation, and is currently under evaluation in a phase I 
clinical study for asthma.
objective: To test the hypothesis that RNS60 reduces tissue damage after acute myocardial infarction, we conducted studies in a porcine model of 
myocardial ischemia/reperfusion.
methods: Male pigs (25-35 kg) were subjected to myocardial ischemia for 60 or 90 minutes and treated with RNS60 or normal saline (NS) by 
single intracoronary injection (0.1 mL/kg) at reperfusion and by continuous intravenous infusion (1.0 mL/kg/hour) following reperfusion. Animals 
were sacrificed on day 2 or day 4, and the size of the infarct area was measured after staining with Evans Blue and triphenyltetrazolium chloride 
(TTC). Apoptosis in the peri-infarct region was measured by counting caspase 3-positive cells.
results: Ischemia for 60 minutes followed by reperfusion for 4 days caused infarcts measuring 44% ± 6% of the area at risk (AAR) in NS-treated 
animals (n=14). RNS60 treatment reduced the infarct size by 32 % (n=13, P<0.001). In addition, the number of caspase 3-positive cells was 
significantly reduced in the RNS60 group compared to controls (17% reduction, P<0.05). Ischemia for 90 minutes caused infarcts measuring 61% 
± 5% of the AAR in the NS group (n=8), and RNS60 still achieved a consistent, non-significant trend towards reduced infarct size (12% reduction, 
n=8, P=0.098). Furthermore, RNS60 treatment in this study resulted in a survival benefit. Only 1 out of 9 (11%) animals died in the RNS60 group 
compared to 6 out of 14 (46%) enrolled into the control group.
conclusion: The ability of a saline-based therapeutic containing charge-stabilized nanostructures to reduce ischemia/reperfusion injury suggests 
novel possibilities to develop therapeutics that limit cardiac damage after coronary revascularization procedures.
